- Home
- QVCGA vs GDTC Comparison
QVCGA vs GDTC Comparison
Compare QVCGA & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGA
- GDTC
- Stock Information
- Founded
- QVCGA 1991
- GDTC 2018
- Country
- QVCGA United States
- GDTC Singapore
- Employees
- QVCGA N/A
- GDTC N/A
- Industry
- QVCGA
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- QVCGA
- GDTC Health Care
- Exchange
- QVCGA NYSE
- GDTC Nasdaq
- Market Cap
- QVCGA 26.1M
- GDTC 28.0M
- IPO Year
- QVCGA N/A
- GDTC 2023
- Fundamental
- Price
- QVCGA $2.99
- GDTC $2.14
- Analyst Decision
- QVCGA
- GDTC Buy
- Analyst Count
- QVCGA 0
- GDTC 1
- Target Price
- QVCGA N/A
- GDTC $5.00
- AVG Volume (30 Days)
- QVCGA 121.5K
- GDTC 5.9K
- Earning Date
- QVCGA 08-07-2025
- GDTC 01-01-0001
- Dividend Yield
- QVCGA N/A
- GDTC N/A
- EPS Growth
- QVCGA N/A
- GDTC N/A
- EPS
- QVCGA N/A
- GDTC N/A
- Revenue
- QVCGA $9,800,000,000.00
- GDTC $368,838.00
- Revenue This Year
- QVCGA $2.89
- GDTC $5.37
- Revenue Next Year
- QVCGA $0.45
- GDTC N/A
- P/E Ratio
- QVCGA N/A
- GDTC N/A
- Revenue Growth
- QVCGA N/A
- GDTC N/A
- 52 Week Low
- QVCGA $2.27
- GDTC $1.20
- 52 Week High
- QVCGA $39.74
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- QVCGA N/A
- GDTC 44.67
- Support Level
- QVCGA N/A
- GDTC $2.08
- Resistance Level
- QVCGA N/A
- GDTC $2.31
- Average True Range (ATR)
- QVCGA 0.00
- GDTC 0.11
- MACD
- QVCGA 0.00
- GDTC -0.00
- Stochastic Oscillator
- QVCGA 0.00
- GDTC 12.18
About QVCGA QVC GROUP INC
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.